Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Sep 22, 2007

29777_dirs_2007-09-21_a4644282-3f8f-4fd2-b3c2-16a26f2b195c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-09-19

Reporting Person: Chen Thomas F (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-09-19 Common shares without par value M 15161 $42.4978 Acquired 115771 Direct
2007-09-19 Common shares without par value F 13259 $53.60 Disposed 102512 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-09-19 Option (right to buy) $42.4978 M 15161 Disposed 2009-02-11 common shares (15161) Direct
2007-09-19 Option (right to buy) $53.60 A 13259 Acquired 2009-02-11 common shares (13259) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 17329 Indirect
Common shares without par value 23798 Indirect
Common shares without par value 2476 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 18, 2007.

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.